<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Mutation of the p53 <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> suppressor is associated with disease progression, therapeutic resistance, and poor prognosis in patients with lymphoid <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignancies</z:e> and can occur in approximately 50% of Burkitt <z:hpo ids='HP_0002665'>lymphomas</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Thus, new therapies are needed to specifically target p53-deficient <z:hpo ids='HP_0002665'>lymphomas</z:hpo> with increased efficacy </plain></SENT>
<SENT sid="2" pm="."><plain>In the current study, the specific impact of inhibition of the small GTPase Rac1 on p53-deficient B- and T-<z:hpo ids='HP_0002665'>lymphoma</z:hpo> cells was investigated </plain></SENT>
<SENT sid="3" pm="."><plain>p53 deficiency resulted in increased Rac1 activity in both B-cell and T-cell lines, and its suppression was able to abrogate p53 deficiency-mediated <z:hpo ids='HP_0002665'>lymphoma</z:hpo> cell proliferation </plain></SENT>
<SENT sid="4" pm="."><plain>Further, Rac targeting resulted in <z:mp ids='MP_0006042'>increased apoptosis</z:mp> via a p53-independent mechanism </plain></SENT>
<SENT sid="5" pm="."><plain>By probing multiple signaling axes and performing rescue studies, we show that the antiproliferative effect of Rac1 targeting in <z:hpo ids='HP_0002665'>lymphoma</z:hpo> cells may involve the PAK and Akt signaling pathway, but not the <z:chebi fb="0" ids="52290">mitogen</z:chebi>-activated protein (MAP) kinase pathway </plain></SENT>
<SENT sid="6" pm="."><plain>The effects of inhibition of Rac1 were extended in vivo where Rac1 targeting was able to specifically impair p53-deficient <z:hpo ids='HP_0002665'>lymphoma</z:hpo> cell growth in mouse xenografts and postpone <z:e sem="disease" ids="C0598766" disease_type="Neoplastic Process" abbrv="">lymphomagenesis</z:e> <z:hpo ids='HP_0003674'>onset</z:hpo> in murine transplantation models </plain></SENT>
<SENT sid="7" pm="."><plain>Because the Rac1 signaling axis is a critical determinant of <z:mpath ids='MPATH_3'>apoptosis</z:mpath> and <z:mp ids='MP_0002006'>tumorigenesis</z:mp>, it may represent an important basis for therapy in the treatment of p53-deficient <z:hpo ids='HP_0002665'>lymphomas</z:hpo> </plain></SENT>
</text></document>